Evidence map›Paper›PMID 37747038›Full record

ArticleActa crystallographica. Section D, Structural biology2023

Increasing the bulk of the 1TEL-target linker and retaining the 10×His tag in a 1TEL-CMG2-vWa construct improves crystal order and diffraction limits.

Parag L Gajjar, Maria J Pedroza Romo, Celeste M Litchfield, Miles Callahan, Nathan Redd, Supeshala Nawarathnage, Sara Soleimani, Jacob Averett, Elijah Wilson, Andrew Lewis and 5 more

Abstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Optimal 1TEL-target protein linker character is target protein-dependent.Acta crystallographica. Section D, Structural biology · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Parag L GajjarDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.ORCID 0000-0001-7960-7320
Maria J Pedroza RomoDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.ORCID 0000-0002-7441-3874
Celeste M LitchfieldDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.
Miles CallahanDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.ORCID 0000-0003-2837-2191
Nathan ReddDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.
Supeshala NawarathnageDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.ORCID 0000-0002-8850-6625
Sara SoleimaniDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.
Jacob AverettDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.ORCID 0000-0002-2287-1590
Elijah WilsonDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.ORCID 0000-0001-5009-2685
Andrew LewisDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.ORCID 0000-0002-0734-3028
Cameron StewartDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.
Yi Jie TsengDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.ORCID 0000-0003-3022-2096
Tzanko DoukovMacromolecular Crystallography Group, Structural Molecular Biology Resource, Stanford Synchrotron Radiation Lightsource, Menlo Park, California, USA.ORCID 0000-0001-8625-2572
Andrey LebedevScientific Computing, STFC Rutherford Appleton Laboratory, Didcot OX11 0QX, United Kingdom.ORCID 0000-0003-2261-0945
James D MoodyDepartment of Chemistry and Biochemistry, Brigham Young University, 701 East University Parkway, Provo, UT 84602, USA.ORCID 0000-0003-2266-5348

Funding

A Synchrotron Radiation Structural Biology ResourcesP30GM133894 · NIGMS · STANFORD UNIVERSITY · PI Aina E. Cohen, KEITH O HODGSON · 2020 to 2026
$43.3M
TELSAM polymers are powerful crystallization chaperones meriting continued investigation (Diversity Supplement)R15GM146209 · NIGMS · BRIGHAM YOUNG UNIVERSITY · PI MOODY, JAMES DANIEL · 2022 to 2024
$520k
NIGMS NIH HHS GM146209NIGMS NIH HHS P30 GM133894NIGMS NIH HHS P30GM133894NIGMS NIH HHS R15 GM146209
6 · The paper itself

Abstract

TELSAM-fusion crystallization has the potential to become a revolutionary tool for the facile crystallization of proteins. TELSAM fusion can increase the crystallization rate and enable crystallization at low protein concentrations, in some cases with minimal crystal contacts [Nawarathnage et al. (2022), Open Biol. 12, 210271]. Here, requirements for the linker composition between 1TEL and a fused CMG2 vWa domain were investigated. Ala-Ala, Ala-Val, Thr-Val and Thr-Thr linkers were evaluated, comparing metrics for crystallization propensity and crystal order. The effect on crystallization of removing or retaining the purification tag was then tested. It was discovered that increasing the linker bulk and retaining the 10×His purification tag improved the diffraction resolution, likely by decreasing the number of possible vWa-domain orientations in the crystal. Additionally, it was discovered that some vWa-domain binding modes are correlated with scrambling of the 1TEL polymer orientation in crystals and an effective mitigation strategy for this pathology is presented.

Indexed as

ProteinsCrystallizationProteins1TELANTXR2best practicesCMG2polymer flippingpolymer-mediated protein crystallizationTELSAMvWa domains

Identifiers

PMID37747038
PMCPMC10565734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.